CM
CVAC

Caption Management’s CureVac CVAC Stock Holding History

Caption Management’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-20,000
Closed -$68K – 1347
2024
Q2 		$68K Buy
+20,000
New +$65.4K ﹤0.01% 1043
2023
Q2 		– Sell
-10,297
Closed -$71.8K – 1158
2023
Q1 		$71.8K Sell
10,297
-21,167
-67% -$185K ﹤0.01% 982
2022
Q4 		$190K Buy
31,464
+27,600
+714% +$204K ﹤0.01% 1071
2022
Q3 		$31K Buy
3,864
+3,237
+516% +$37.7K ﹤0.01% 1407
2022
Q2 		$9K Sell
627
-66,000
-99% -$1.09M ﹤0.01% 1384
2022
Q1 		$1.31M Buy
66,627
+5,987
+10% +$120K 0.02% 877
2021
Q4 		$2.08M Buy
60,640
+52,640
+658% +$2.12M 0.02% 778
2021
Q3 		$437K Buy
+8,000
New +$482K 0.01% 1227

Other funds holding CVAC

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Caption Management's CVAC Position: Q3 2024 in Review

Caption Management sold out of CureVac (CVAC) in Q3 2024, closing a stake of 20,000 shares — an estimated $68K sold.

Caption Management first reported a position in CVAC in Q3 2021 and held it in 8 quarters. The position peaked at $2.08M in Q4 2021. 81 funds tracked by Wall St. Rank hold CVAC as of Q3 2024.

  • Caption Management reported no remaining CureVac position as of Q3 2024 after selling out during the quarter.
  • Caption Management sold 20,000 CureVac shares in Q3 2024, an estimated $68K.
  • Caption Management first reported a position in CureVac in Q3 2021 and held it in 8 quarters.
  • Caption Management's CureVac position peaked at $2.08M in Q4 2021.
  • 81 funds tracked by Wall St. Rank held CureVac as of Q3 2024.

Based on Caption Management's 13F filing for Q3 2024, filed 14 Nov 2024.